Pharmacoeconomic evaluation on the sequential therapy with Cefriaxone & Cefaclor on bronchopneumonia in children

Objective To pharmacoeconomically evaluate two medications on bronchopneumonia in children. Methods 67 cases with bronchopneumonia were divided into two groups A and B. Group A includes 32 cases was accepted sequential therapy of Cefriaxone Cefaclor while group B includes 35 cases with successive intravenous Ceftriaxone. Using cost-minimization analysis two therapeutic schems were compared. Results The effectiveness had not significant difference in two groups P0.05the reduced average cost of antibiotic cost for treatment during hospitalization and total cost for treatment were significant in group A than group B P0.01. Conclusion The present study showed that sequential therapy with Ceftriaxone Cefaclor is a safe effective and economic medication on bronchopneumonia in children.